{"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "SciTechDaily"}, "author": null, "title": "Alzheimer\u2019s Breakthrough: Popular Diabetes Drug Ozempic Linked to Much Lower Risk - SciTechDaily", "description": "Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs. Researchers at Case Western Reserve School of Medicine have found that semaglutide, a popular drug \u2026", "url": "https://scitechdaily.com/alzheimers-breakthrough-popular-diabetes-drug-ozempic-linked-to-much-lower-risk/", "urlToImage": "https://scitechdaily.com/images/Alzheimers-Dementia-Brain-Disease-Concept.jpg", "publishedAt": "2024-10-27T10:34:16Z", "content": "Researchers have discovered that semaglutide, a diabetes and weight-loss medication sold under the brand names Wegovy and Ozempic, might significantly reduce the risk of Alzheimer\u2019s in type 2 diabete\u2026 [+3673 chars]"}]}